Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer

被引:0
|
作者
Liu, Mengmei [1 ]
Yan, Guanghong [1 ]
Li, Yanli [2 ]
You, Ruiming [2 ]
Liu, Lizhu [2 ]
Zhang, Dafu [2 ]
Yang, Guangjun [2 ]
Dong, Xingxiang [2 ]
Ding, Yingying [2 ]
Yan, Shan [3 ]
You, Dingyun [1 ,2 ]
Li, Zhenhui [2 ]
机构
[1] Kunming Med Univ, Yunnan Prov Key Lab Publ Hlth & Biosafety, 1168 West Chunrong Rd, Kunming 650500, Yunnan, Peoples R China
[2] Kunming Med Univ, Yunnan Canc Hosp, Affiliated Hosp 3, Yunnan Canc Ctr, Kunming 650118, Peoples R China
[3] Kunming Med Univ, Inst Biomed Engn, 1168 West Chunrong Rd, Kunming 650500, Yunnan, Peoples R China
关键词
NSCLC; Modality; CT; Overall survival; Splenic area; SUPPRESSOR-CELLS; LOCAL RECURRENCE; SURGERY; SPLEEN;
D O I
10.1186/s40644-023-00640-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe correlation between the preoperative splenic area measured on CT scans and the overall survival (OS) of early-stage non-small cell lung cancer (NSCLC) patients remains unclear.MethodsA retrospective discovery cohort and validation cohort consisting of consecutive NSCLC patients who underwent resection and preoperative CT scans were created. The patients were divided into two groups based on the measurement of their preoperative splenic area: normal and abnormal. The Cox proportional hazard model was used to analyse the correlation between splenic area and OS.ResultsThe discovery and validation cohorts included 2532 patients (1374 (54.27%) males; median (IQR) age 59 (52-66) years) and 608 patients (403 (66.28%) males; age 69 (62-76) years), respectively. Patients with a normal splenic area had a 6% higher 5-year OS (n = 727 (80%)) than patients with an abnormal splenic area (n = 1805 (74%)) (p = 0.007) in the discovery cohort. A similar result was obtained in the validation cohort. In the univariable analysis, the OS hazard ratios (HRs) for the patients with abnormal splenic areas were 1.32 (95% confidence interval (CI): 1.08, 1.61) in the discovery cohort and 1.59 (95% CI: 1.01, 2.50) in the validation cohort. Multivariable analysis demonstrated that abnormal splenic area was independent of shorter OS in the discovery (HR: 1.32, 95% CI: 1.08, 1.63) and validation cohorts (HR: 1.84, 95% CI: 1.12, 3.02).ConclusionPreoperative CT measurements of the splenic area serve as a prognostic indicator for early-stage NSCLC patients, offering a novel metric with potential implications for personalized therapeutic strategies in top-tier oncology research.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer
    Mengmei Liu
    Guanghong Yan
    Yanli Li
    Ruiming You
    Lizhu Liu
    Dafu Zhang
    Guangjun Yang
    Xingxiang Dong
    Yingying Ding
    Shan Yan
    Dingyun You
    Zhenhui Li
    [J]. Cancer Imaging, 23
  • [2] Prognostic Impact of Histology on Early-Stage Non-small Cell Lung Cancer
    Maeda, Ryo
    Yoshida, Junji
    Ishii, Genichiro
    Hishida, Tomoyuki
    Nishimura, Mitsuyo
    Nagai, Kanji
    [J]. CHEST, 2011, 140 (01) : 135 - 145
  • [3] Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection
    Yan, Ci Hui
    Lv, Mengguo
    Li, Hui
    Song, Xinmiao
    Yan, Fan
    Cao, Shui
    Ren, Xiubao
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (08) : 1371 - 1378
  • [4] Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection
    Ci Hui Yan
    Mengguo Lv
    Hui Li
    Xinmiao Song
    Fan Yan
    Shui Cao
    Xiubao Ren
    [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1371 - 1378
  • [5] Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer
    Ulivi, Paola
    Petracci, Elisabetta
    Marisi, Giorgia
    Baglivo, Sara
    Chiari, Rita
    Billi, Monia
    Canale, Matteo
    Pasini, Luigi
    Racanicchi, Serena
    Vagheggini, Alessandro
    Delmonte, Angelo
    Mariotti, Marita
    Ludovini, Vienna
    Bonafe, Massimiliano
    Crino, Lucio
    Grignani, Francesco
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [6] The prognostic value of the preoperative albumin/globulin and monocyte ratio in resected early-stage non-small cell lung cancer
    Wu, Wenqi
    Zhang, Lening
    Wang, Chen
    Xu, Zhenan
    Feng, Chong
    Zhang, Zhe
    Qin, Dongliang
    Zhang, Chen
    Lin, Fengwu
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (01) : 118 - 123
  • [7] Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer
    Yip, P. Y.
    Cooper, W. A.
    Kohonen-Corish, M. R. J.
    Lin, B. P. C.
    McCaughan, B. C.
    Boyer, M. J.
    Kench, J. G.
    Horvath, L. G.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (04) : 333 - 340
  • [8] Prognostic Value of DNA Ploidy and Nucleotyping in Early-stage Non-small Cell Lung Cancer
    Mao, L.
    Wu, J.
    Lin, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S262 - S262
  • [9] Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer
    Tuminello, Stephanie
    Petralia, Francesca
    Veluswamy, Rajwanth
    Wang, Pei
    Flores, Raja
    Taioli, Emanuela
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (07): : 350 - 355
  • [10] Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer
    Mao, Luning
    Wu, Jianghua
    Zhang, Zhongjie
    Mao, Lijun
    Dong, Yuejin
    He, Zufeng
    Wang, Haiyue
    Chi, Kaiwen
    Jiang, Yumeng
    Lin, Dongmei
    [J]. CANCERS, 2023, 15 (12)